Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
Although these conditions are rare, a proportion of patients with interstitial lung diseases (ILDs) may develop a progressive-fibrosing phenotype. Progressive fibrosis is associated with worsening respiratory symptoms, lung function decline, limited response to immunomodulatory therapies, decreased...
Main Authors: | Vincent Cottin, Nikhil A. Hirani, David L. Hotchkin, Anoop M. Nambiar, Takashi Ogura, María Otaola, Dirk Skowasch, Jong Sun Park, Hataya K. Poonyagariyagorn, Wim Wuyts, Athol U. Wells |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2018-12-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/27/150/180076.full |
Similar Items
-
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
by: Vincent Cottin
Published: (2019-10-01) -
Fibrosing interstitial lung diseases: knowns and unknowns
by: Vincent Cottin, et al.
Published: (2019-02-01) -
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
by: Vincent Cottin, et al.
Published: (2021-03-01) -
Monitoring and management of fibrosing interstitial lung diseases: a narrative review for practicing clinicians
by: Anoop M. Nambiar, et al.
Published: (2021-09-01) -
Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next Stage
by: Laurens J. De Sadeleer, et al.
Published: (2020-06-01)